Gastrointestinal Stromal Tumor Gist Drug Market Insights: Global Industry Analysis, Market Drivers, Restraints, Opportunities, Applications, Trends And Forecasts 2020-2026

The Gastrointestinal Stromal Tumor Gist Drug Market report offers perceptive information regarding drivers, restraints, opportunities, and trends of the Gastrointestinal Stromal Tumor Gist Drug Market. With the use of historic data from (period), the Gastrointestinal Stromal Tumor Gist Drug Market report offers Y-o-Y growth and CAGR until 2026. The insightful data offered in the report makes it an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts and stakeholders that are in search of major industry information in ready-to-access documents with clearly presented tables and graphs.

The global market for Gastrointestinal Stromal Tumor Gist Drug Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2020.

The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.

The key manufacturers in this market include

  • Ariad Pharmaceuticals, Inc.
  • Arog Pharmaceuticals, Inc.
  • Array BioPharma Inc.
  • Astex Pharmaceuticals, Inc.
  • Blueprint Medicines Corporation
  • Boston Biomedical, Inc.
  • Calithera Biosciences, Inc.
  • Chipscreen Biosciences Ltd
  • Deciphera Pharmaceuticals, LLC
  • F. Hoffmann-La Roche Ltd.
  • Horizon Pharma Plc
  • Immunicum AB
  • Jiangsu Hengrui Medicine Co., Ltd.
  • Kolltan Pharmaceuticals, Inc.
  • Natco Pharma Limited
  • Nerviano Medical Sciences S.r.l.
  • Novartis AG
  • Omeros Corporation

On the basis of region, the market is divided into:

  • North America (U.S. and Canada)
  • Latin America (Brazil, Mexico, Argentina, Columbia, and Rest of Latin America)
  • Europe (Germany, the U.K., France, Russia, Italy, and Rest of Europe)
  • Asia Pacific (China, Japan, South Korea, India, Southeast Asia, and Rest of Asia Pacific)
  • Middle East (Saudi Arabia, UAE, Egypt, and Rest of Middle East)
  • Africa (North Africa, Central Africa, and South Africa)

By the product type, the market is primarily segmented into

  • Amcasertib
  • Anagrelide hydrochloride CR
  • APG-1351
  • Binimetinib
  • Others

By the End-user Applications, the market is primarily segmented into

  • Clinic
  • Hospital
  • Others

We can also provide the customized separate regional or country-level reports, for the following regions:

  • North America
    • United States
    • Canada
    • Mexico
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • Indonesia
    • Thailand
    • Malaysia
    • Philippines
    • Vietnam
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Central & South America
    • Brazil
  • Middle East & Africa
    • Turkey
    • GCC Countries
    • Egypt
    • South Africa

Key Highlights of the Report:

  • Growth opportunities in the global Gastrointestinal Stromal Tumor Gist Drug Market across major regions during the forecast period.
  • Role of emerging markets in the global Gastrointestinal Stromal Tumor Gist Drug Market and the scenario during the 2020-2026.
  • Technological and product developments that influence growth of the market.
  • New trends and advancements in the global Gastrointestinal Stromal Tumor Gist Drug Market.
  • Insight on various product types and their respective market shares in the overall market.

The report offers you perceptive data of the market and highlights its commercial landscape and pivotal factors that propel and hinder the market growth. It also evaluates production processes, major bottlenecks, and solutions to reduce risks associated with R&D and focuses on major growth strategies adopted by leading market players. The report accurately projects the global market value and regional share during the forecast period

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

  • Raw material suppliers
  • Distributors/traders/wholesalers/suppliers
  • Regulatory bodies, including government agencies and NGO
  • Commercial research & development (R&D) institutions
  • Importers and exporters
  • Government organizations, research organizations, and consulting firms
  • Trade associations and industry bodies
  • End-use industries

Available Customizations

At Worldwide Market Reports we offer tailored researches to help our clients stay ahead in competition.

Table of Contents

Executive Summary
1 Industry Overview of Gastrointestinal Stromal Tumor (GIST) Drug
1.1 Definition of Gastrointestinal Stromal Tumor (GIST) Drug
1.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
1.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Amcasertib
1.2.3 Anagrelide hydrochloride CR
1.2.4 APG-1351
1.2.5 Binimetinib
1.2.6 Others
1.3 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Applications
1.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Gastrointestinal Stromal Tumor (GIST) Drug Overall Market
1.4.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (2014-2025)
1.4.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Production (2014-2025)
1.4.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.5 China Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)
1.4.8 India Gastrointestinal Stromal Tumor (GIST) Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
2.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
2.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug

3 Development and Manufacturing Plants Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
3.1 Capacity and Commercial Production Date
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Gastrointestinal Stromal Tumor (GIST) Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Gastrointestinal Stromal Tumor (GIST) Drug Production and Capacity Analysis
4.2 Gastrointestinal Stromal Tumor (GIST) Drug Revenue Analysis
4.3 Gastrointestinal Stromal Tumor (GIST) Drug Price Analysis
4.4 Market Concentration Degree

5 Gastrointestinal Stromal Tumor (GIST) Drug Regional Market Analysis
5.1 Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
5.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions
5.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions
5.2 Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions
5.3 North America Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.3.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Production
5.3.2 North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.4.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Production
5.4.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.5 China Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.5.1 China Gastrointestinal Stromal Tumor (GIST) Drug Production
5.5.2 China Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.6 Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.6.1 Japan Gastrointestinal Stromal Tumor (GIST) Drug Production
5.6.2 Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.7 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.7.1 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production
5.7.2 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Import and Export
5.8 India Gastrointestinal Stromal Tumor (GIST) Drug Market Analysis
5.8.1 India Gastrointestinal Stromal Tumor (GIST) Drug Production
5.8.2 India Gastrointestinal Stromal Tumor (GIST) Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Gastrointestinal Stromal Tumor (GIST) Drug Import and Export

6 Gastrointestinal Stromal Tumor (GIST) Drug Segment Market Analysis (by Type)
6.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Type
6.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type
6.3 Gastrointestinal Stromal Tumor (GIST) Drug Price by Type

7 Gastrointestinal Stromal Tumor (GIST) Drug Segment Market Analysis (by Application)
7.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Application
7.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Application (2014-2019)

8 Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers Analysis
8.1 Ariad Pharmaceuticals, Inc.
8.1.1 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.1.2 Ariad Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Arog Pharmaceuticals, Inc.
8.2.1 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.2.2 Arog Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Array BioPharma Inc.
8.3.1 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.3.2 Array BioPharma Inc. Product Introduction, Application and Specification
8.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Astex Pharmaceuticals, Inc.
8.4.1 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.4.2 Astex Pharmaceuticals, Inc. Product Introduction, Application and Specification
8.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Blueprint Medicines Corporation
8.5.1 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.5.2 Blueprint Medicines Corporation Product Introduction, Application and Specification
8.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Boston Biomedical, Inc.
8.6.1 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.6.2 Boston Biomedical, Inc. Product Introduction, Application and Specification
8.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Calithera Biosciences, Inc.
8.7.1 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.7.2 Calithera Biosciences, Inc. Product Introduction, Application and Specification
8.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Chipscreen Biosciences Ltd
8.8.1 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.8.2 Chipscreen Biosciences Ltd Product Introduction, Application and Specification
8.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Deciphera Pharmaceuticals, LLC
8.9.1 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.9.2 Deciphera Pharmaceuticals, LLC Product Introduction, Application and Specification
8.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 F. Hoffmann-La Roche Ltd.
8.10.1 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
8.10.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
8.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Horizon Pharma Plc
8.12 Immunicum AB
8.13 Jiangsu Hengrui Medicine Co., Ltd.
8.14 Kolltan Pharmaceuticals, Inc.
8.15 Natco Pharma Limited
8.16 Nerviano Medical Sciences S.r.l.
8.17 Novartis AG
8.18 Omeros Corporation

9 Development Trend of Analysis of Gastrointestinal Stromal Tumor (GIST) Drug Market
9.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Trend Analysis
9.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Gastrointestinal Stromal Tumor (GIST) Drug Regional Market Trend
9.2.1 North America Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.3 China Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.4 Japan Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.5 Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.2.6 India Gastrointestinal Stromal Tumor (GIST) Drug Forecast 2019-2025
9.3 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend (Product Type)
9.4 Gastrointestinal Stromal Tumor (GIST) Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Gastrointestinal Stromal Tumor (GIST) Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Table
List of Tables and Figures
Figure Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Types in 2018
Figure Amcasertib Product Picture
Figure Anagrelide hydrochloride CR Product Picture
Figure APG-1351 Product Picture
Figure Binimetinib Product Picture
Figure Others Product Picture
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Applications in 2018
Figure Clinic
Figure Hospital
Figure Others
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) (2014-2025)
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) (2014-2025)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Market Size (Million USD) (2014-2025)
Table Gastrointestinal Stromal Tumor (GIST) Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in 2018
Figure Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Plants Distribution
Table Gastrointestinal Stromal Tumor (GIST) Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Gastrointestinal Stromal Tumor (GIST) Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Gastrointestinal Stromal Tumor (GIST) Drug Production Share by Manufacturers in 2018
Table Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Gastrointestinal Stromal Tumor (GIST) Drug Revenue Share by Manufacturers in 2018
Table Gastrointestinal Stromal Tumor (GIST) Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production by Regions 2014-2019 (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Regions 2014-2019
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share by Regions in 2018
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions 2014-2019
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2018
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Gastrointestinal Stromal Tumor (GIST) Drug Consumption Market Share by Regions 2014-2019
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Gastrointestinal Stromal Tumor (GIST) Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Gastrointestinal Stromal Tumor (GIST) Drug Market Share by Application (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Introduction, Application and Specification
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Main Business and Markets Served
Table Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Table Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Production Sites and Area Served
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Gastrointestinal Stromal Tumor (GIST) Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Gastrointestinal Stromal Tumor (GIST) Drug by Application (2019-2025)
Table Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table Gastrointestinal Stromal Tumor (GIST) Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Choose License Type

Happy To Assist You

Contact Images

We will be happy to help you find what you need. Please call us or write to us:

Frequently Asked Questions

This report incorporates the analysis of factors that augments the market growth. Report presents competitive landscape of the global market. This also provides the scope of different segments and applications that can potentially influence the market in the future. The analysis is based on current market trends and historic growth data. It includes detailed market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast. The market was valued at xxx Million US$ in 2019, and is expected to grow at a CAGR of xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by:
  • Product Types
  • Drug Class
  • Indication
  • Applications
  • Services Types
  • End-users
  • Distribution channel
  • Regions
The report share key insights on the following:
  • Current market size
  • Market forecast
  • Market opportunities
  • Key drivers
  • Restraints
  • Pipeline Analysis
  • Incidence Rate
  • Epidemiology Analysis
  • Prevalence rate
  • Regulatory scenario
  • Industry trend
  • Pestle Analysis
  • Porter’s Analysis
  • New product approvals/launch
  • Promotion and marketing initiatives
  • Pricing analysis
  • Export-import analysis
  • Trade analysis
  • Competitive landscape
It helps the businesses in making investments decisions.
Customization helps the organization to gain insight on specific segments and regions of interest. Thus, WMR offers tailored report information based on business requirement in order to take strategic calls.
Contact us

mapicon
Sales Office (U.S.):
Worldwide Market Reports, 1001 4th Ave, #3200 Seattle, WA 98154, U.S.

mapicon+1-415-871-0703

mapicon
Asia Pacific Intelligence Center (India):
Worldwide Market Reports 203, 2nd Floor, Bremen Business Center, Aundh, Pune, Maharashtra 411007, India.

Newsletter

Want us to send you latest updates of the current trends, insights, and more, signup to our newsletter (for alerts, special offers, and discounts).

Secure Payment By:
paymenticon

This website is secured Origin CA certificate on the server, Comodo, Firewall and Verified Sitelock Malware Protection

secureimg

© 2020 Worldwide Market Reports. All rights reserved